Alkem Laboratories Limited has announced that its Chief Executive Officer, Dr. Vikas Gupta, has decided to step down from his position to pursue new professional opportunities. Dr. Gupta will remain with the organization until June 30, 2026, to ensure a seamless transition of his leadership responsibilities and ongoing strategic initiatives. The company expressed appreciation for his contributions to strengthening its market position and R&D pipeline during his tenure.
Leadership Transition at Alkem
Alkem Laboratories has confirmed the departure of Dr. Vikas Gupta, who has served as the company’s Chief Executive Officer for the past several years. In his formal resignation, Dr. Gupta cited a desire to explore new professional goals that align with his long-term career aspirations. To facilitate a smooth changeover, he will continue to serve as CEO until June 30, 2026.
Reflecting on Tenure
During his time at the helm, Dr. Gupta played a pivotal role in shaping the company’s growth trajectory. Key highlights of his tenure include:
- Strengthening the company’s competitive market position.
- Advancing the organization’s R&D pipeline.
- Navigating the complexities of the global pharmaceutical landscape.
Dr. Gupta expressed his gratitude to the Promoter Family and the Board of Directors for their leadership and trust, noting that his efforts were focused on making Alkem a future-ready organization. He remains committed to ensuring that all ongoing strategic projects are handed over effectively before his final date of June 30, 2026.
Source: BSE
